Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Topical Calcineurin Inhibitors Effective Treatment Option for Pediatric Periorificial Dermatitis

Key clinical point: Topical calcineurin inhibitors (TCIs) are a treatment option for pediatric periorificial dermatitis (POD).

Major finding: The researchers observed complete response in 65% of patients treated with TCI alone.

Study details: A retrospective cohort study of 132 pediatric patients with POD.

Disclosures: The researchers reported having no financial disclosures.


Ollech A et al. SPD 2019, poster 23.